Proposed Standard Weight ( Ws ) Equations for Arctic Grayling

2021 ◽  
Author(s):  
Andrew T. Gilham ◽  
Michael L. Brown ◽  
George R. Jordan
Keyword(s):  
Arctic Grayling ◽  
Standard Weight

scholarly journals Development of osmotic vacuolization of proximal tubular epithelial cells following treatment with sodium-glucose transport protein 2 inhibitors in type II diabetes mellitus patients-3 case reports

2021 ◽  
Author(s):  
Shun Watanabe ◽  
Naoki Sawa ◽  
Hiroki Mizuno ◽  
Masayuki Yamanouchi ◽  
Tatsuya Suwabe ◽  
...  
Keyword(s):  
Serum Creatinine ◽  
Type Ii Diabetes ◽  
Sglt2 Inhibitor ◽  
Type Ii Diabetes Mellitus ◽  
Proximal Tubules ◽  
Type Ii ◽  
Tubular Epithelial Cells ◽  
Proximal Tubular Epithelial Cells ◽  
Proximal Tubular ◽  
Standard Weight

AbstractWe encountered 3 cases of acute kidney injury that occurred after treatment with a SGLT2 inhibitor. In case 1, serum creatinine increased from 1.65 to 3.0 mg/dL, in case 2, serum creatinine increased from 1.03 to 1.21 mg/dL, and in case 3, serum creatinine increased from 0.8 to 1.1 mg/dL. Renal biopsy showed isometric vacuolization on tubules, that was completely negative for Periodic acid-Schiff (PAS) stain in case 1, and was partially negative for PAS stain in case 2 and 3, consistent with osmotic vacuolization. Immunohistochemical analysis showed positive staining for CD138 and CD10 indicating the proximal tubules in the vacuolar lesions. 3 patients were obese with body mass index of more than 30, and showed an increase in serum renin. In conclusion, in type II diabetes mellitus (T2DM), individuals that remain within their standard weight range, SGLT2 inhibitor treatment does not result in osmotic vacuolization of proximal tubular epithelial cells and AKI. However, treatment with a SGLT2 inhibitor may cause damage of the proximal tubules resulting in AKI in T2DM individuals who do not remain within their standard weight range, due to an overdose lavage of sugar in the urine and dehydration.

Infant Warmer Equipped with Digital Weight Scales

2021 ◽  
Vol 14 (2) ◽  
pp. 68-72
Author(s):  
Muhammad Jundi Al'Aziz ◽  
Bambang Guruh Irianto ◽  
Abd Kholiq
Keyword(s):  
Body Weight ◽  
Human Body ◽  
Maximum Weight ◽  
Maximum Capacity ◽  
External Calibration ◽  
Measurement Results ◽  
The World ◽  
Measured Load ◽  
Error Percentage ◽  
Standard Weight

Scales Scales in the world of health are used to measure human body weight such as baby scales. Newborns are very important to be weighed because it is used as a measure of the baby's health indication ranging from 2.4 kg to 4.2 kg. The author makes a tool for this to make it easier for users to weigh with a 7 segment display on the Infant Warmer tool and external calibration. By using a loadcell sensor with a maximum capacity of 5 kg, the loadcell can detect the weight of the load where the voltage generated by the loadcell of 0.7 mV at a load of 1 kg is amplified to 0.62 V by the PSA circuit using the AD620 IC and then processed by Arudino UNO as a microcontroller. The weight results will be displayed on the 7Segment display located on the Infant Warmer tool. In the study, the measured load included a weight of 0 kg to a maximum weight of 5 kg. The measurement of the data results was carried out 5 times each by comparing the modules that had been made with the standard weight, namely (lead). The data from the measurement results of the research module shows that when the weight of the measurement at 1 kg has an error percentage of 0.08%. Measurements at a weight of 2 kg have an error percentage of 0.05%. Measurement of weight 3 kg has a presentation error of 0.01%. Measurements at a weight of 4 kg have a presentation error of 0.02%. And measurements at a weight of 5 kg have an error percentage of 0.04%. Then the data from the measurement results of the research module shows the largest error presentation of 0.08% at a weight of 1 kg. And the data from the measurement results of the research module shows the smallest error presentation of 0.01% at a weight of 3 kg. Making a research module in the form of a scale placed on an infant warmer can make it easier for the wearer.

scholarly journals Standard weight (Ws) equation for Brook Trout in southern Appalachian Mountains streams

2020 ◽  
Author(s):  
Audrey C. Harris ◽  
R. Daniel Hanks ◽  
Jacob M. Rash ◽  
David W. Goodfred ◽  
Yoichiro Kanno
Keyword(s):  
Brook Trout ◽  
Regression Line ◽  
Appalachian Mountains ◽  
Relative Weight ◽  
Habitat Characteristics ◽  
Minimum Size ◽  
Southern Appalachian Mountains ◽  
Percentile Method ◽  
Southern Appalachian ◽  
Standard Weight

Brook Trout Salvelinus fontinalis in southern Appalachian Mountains streams of the USA occur at the southernmost portion of their native range, and occupy small, isolated, and low-productivity headwater streams. The existing standard weight (Ws) equation is applicable only to Brook Trout > 120 mm total length (TL), but many individuals in the region are smaller than this minimum size threshold due to their habitat characteristics. Here, we developed a new Ws equation for Brook Trout in southern Appalachian Mountains streams using length-weight data on 72,502 individuals. The weighted quadratic empirical-percentile method minimized length-related bias in relative weight compared to the regression-line-percentile and weighted linear empirical-percentile methods. The proposed Ws equation was: log10W = -3.364 + 1.378 x log10L + 0.397 x (log10L)2, where W was weight (g) and L was TL (mm). The new equation characterized body condition of Brook Trout in southern Appalachian Mountains streams more accurately than the existing equation.

scholarly journals A Comparison of an Individualized and Weight-Based Opioid Protocols for the Treatment of Vaso-Occlusive Episodes in the Emergency Department

Blood ◽  
2016 ◽  
Vol 128 (22) ◽  
pp. 3674-3674
Author(s):  
Paula J Tanabe ◽  
Regina D. Crawford ◽  
Susan Silva ◽  
Jeffrey A. Glassberg ◽  
Christopher Miller ◽  
...  
Keyword(s):  
Emergency Department ◽  
Medical Record ◽  
Research Funding ◽  
Site Effects ◽  
Assisted Ventilation ◽  
Research Staff ◽  
Pain Scores ◽  
Ed Visits ◽  
Secondary Outcomes ◽  
Standard Weight

Abstract Introduction: Vaso-occlusive episodes are the most common complication experienced by individuals with sickle cell disease (SCD). Treatment in an emergency department (ED) is often required and significant variability in care exists. In 2014, NHLBI published evidence based recommendations suggesting treatment with either an individualized opioid dosing or standard weight-based protocol; however the supporting evidence grade was Consensus - Panel Expertise. As outlined in the results section, the aim of this project was to compare change in pain scores, patient safety and system utilization variables between patients randomized to an individualized or weight based (standard) dosing protocol for treatment of VOC from arrival to discharge in an ED setting. Methods: A randomized controlled trial was conducted in two EDs (OH and NY). Adults with SCD were eligible for inclusion and recruited during a hospitalization, clinic visit or at the end of an ED visit. Patients were randomized to treatment with an individualized opioid dosing protocol (developed by the SCD physician based on patients' prior opioid use) or standard weight based protocol. Both protocols were supported by the NHLBI recommendations for treatment of VOE (2014) to include repeat dosing. Protocols were made available on the electronic medical record for future ED visits (up to five visits/patient), should they occur. ED physicians were informed of the protocol and ordered analgesics. Research staff was notified when ED visits occurred for enrolled patients and obtained assessments of pain (0-100 cm VAS) every 30 minutes from placement in the ED to one of 3 study endpoints: 1) 6 hours; 2) decision to admit to the hospital; 3) discharge home. The unit of analysis was the ED visit rather than patient. The primary outcome was change in pain score from arrival to study endpoint. Research staff reviewed the medical record 30 days after the ED visit to determine secondary outcomes of hospital admission, re-admission and new ED visits within 72 hours, 7 and 30 days post the index ED visit. The medical record was reviewed for administration of narcan, intubation, or assisted ventilation. A hierarchical linear mixed effects model adjusting for nested patient and site effects were used to test for a difference in the mean pain change scores in the treatment arms. Generalized Linear Models adjusting for nested patient and site effects were performed to evaluate differences in the dichotomized secondary outcomes. Results: 106 patients enrolled in the study with 52 patients (sites: 25 OH, 27 NY) contributing a total of 126 ED visits over 12 months. Among the 52 patients with visits, the median number of ED visits/patient was 2.0, 58% were male, and the median age was 27 years (range: 21 to 60). No patients in either treatment arm required narcan, intubation, or assisted ventilation. Pain change: Mixed effect model adjusted mean ± standard deviation, higher positive score = greater pain reduction; *Fisher's Exact Test result due to low cell frequency. Conclusions: An individualized opioid dosing protocol resulted in a larger reduction in pain scores and lower hospital admission rate among patients with SCD treated for VOE in two EDs when compared to treatment with a weight-based opioid protocol. However, there was a tendency for more frequent ED re-visits within 72 hours, 7 and 30 days among patients in the individualized opioid dosing protocol. A pragmatic RCT with a larger and more heterogeneous sample of patients and ED settings is required to provide definitive evidence to guide treatment of VOE. Table 1. Table 1. Disclosures Tanabe: NHLBI: Research Funding. Bosworth:WestMeadVaco: Research Funding; CVS carematix: Consultancy; Improved Patient Outcomes: Research Funding; Johnson & Johnson: Consultancy, Research Funding; Genentech: Consultancy; sanofi: Honoraria, Research Funding; Pharma Foundation: Research Funding.

Sign in / Sign up

Export Citation Format

Share Document